PMID: 7581481Jan 1, 1995Paper

The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis

Pharmacogenetics
P Fernandez-Salguero, F Gonzalez

Abstract

The CYP2A subfamily has been characterized in several mammalian species including mouse, rat, rabbit, hamster, cattle and human. Marked species differences have been demonstrated in the catalytic activities and regulation of this subfamily. In humans, the CYP2A genes are found as a cluster on the long arm of chromosome 19 with the CYP2B and CYP2F genes. Marked interindividual differences in expression of the CYP2A6 gene was found in livers analyzed in vitro and in humans phenotyped in vivo by using coumarin, a specific substrate for the enzyme. Efforts are underway to determine the existence of mutant and variant CYP2A6 alleles in the human population. Since CYP2A6 is able to metabolically-activate chemical carcinogens and is expressed in extrahepatic tissue, it will be of interest to determine whether genetic differences in expression of the gene is associated with cancer risk.

Citations

Mar 26, 1998·European Journal of Drug Metabolism and Pharmacokinetics·Y LiE M Sellers
Apr 30, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xin-Yuan ChengHong-Hao Zhou
Sep 15, 2004·Toxicology and Applied Pharmacology·Ting Su, Xinxin Ding
Apr 16, 2003·Analytical Biochemistry·Lilian G YengiC Roland Wolf
Jun 3, 1999·Biochemical Pharmacology·S KoskelaH Raunio
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
Oct 31, 2002·Advanced Drug Delivery Reviews·Chun XuRachel F Tyndale
Apr 27, 2000·Toxicology·M BourianW Legrum
Apr 27, 2000·Toxicology·O PelkonenM Pasanen
Oct 24, 1998·Genes & Development·B BlumbergR M Evans
May 1, 1996·Environmental Health Perspectives·H Bartsch, E Hietanen
May 7, 1999·Environmental Health Perspectives·A Hirvonen
Oct 21, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Elena PirasEva B Brittebo
Jul 4, 2001·Pharmacogenetics·J T KwonT Yokoi
Jan 24, 2002·Therapeutic Drug Monitoring·Rachel F Tyndale, Edward M Sellers
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Aug 26, 1999·Drug Metabolism Reviews·S Ekins, S A Wrighton
Jan 9, 1998·Drug Metabolism Reviews·P Honkakoski, M Negishi
Feb 18, 2015·Drug Metabolism Reviews·Jolantha BeyerleCornelia M Ulrich
Dec 19, 2002·Drug Metabolism Reviews·Miki NakajimaTsuyoshi Yokoi
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H RaunioY Soini
Nov 1, 2009·Environmental Toxicology and Pharmacology·Roongnapa ApinanKesara Na-Bangchang
Sep 22, 2006·International Journal of Cancer. Journal International Du Cancer·Miki NakajimaTsuyoshi Yokoi
Oct 12, 2007·Basic & Clinical Pharmacology & Toxicology·Blanca SinuésAngel Ferrandez-Longás
Sep 1, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Amit SharmaDevendra Parmar
Jan 16, 2007·Drug Metabolism and Pharmacokinetics·Sompop PeamkrasatamKrongtong Yoovathaworn
Aug 26, 1998·Toxicology and Applied Pharmacology·S L BornL D Lehman-McKeeman
Feb 14, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A RossiniL F Ribeiro Pinto
Jun 8, 2001·Human & Experimental Toxicology·I CokS Sardaş
Dec 8, 2004·Toxicologic Pathology·Mary Beth GenterJoanna Groden
Mar 27, 2002·Biological & Pharmaceutical Bulletin·Fusako NagaiHiro-Omi Tamura
Nov 3, 1998·Clinical Pharmacology and Therapeutics·M P NowakR F Tyndale
Apr 11, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shotaro UeharaHiroshi Yamazaki
Feb 9, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ting LiuShuqing Chen
Jan 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Marià PitarqueMagnus Ingelman-Sundberg
Nov 6, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ziping BaoJun-Yan Hong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.